Related by context. Frequent words. (Click for all words.) 65 Amrubicin 64 ASA# 64 metastatic renal cell carcinoma 63 pertuzumab 62 NSABP 62 SWOG 61 placebo controlled clinical 61 EORTC 61 randomized Phase III 61 XELOX 61 phase IIa 60 axitinib 60 darapladib 60 decitabine 60 Irinotecan 60 Alemtuzumab 60 Fludara 60 Avastin bevacizumab 60 Pirfenidone 60 GVAX 59 Hycamtin 59 ocrelizumab 59 tocilizumab 59 Taxotere ® 59 Carfilzomib 59 tesmilifene 59 HER2 positive metastatic breast 59 Torisel 59 Telcyta 58 TroVax 58 neoadjuvant therapy 58 multicenter clinical 58 abiraterone acetate 58 metastatic hormone refractory 58 non squamous 58 talabostat 58 vandetanib 58 Trastuzumab 58 HGS ETR1 58 Jevtana 58 HuMax CD# 58 cabazitaxel 58 aflibercept 58 tipranavir 58 Nexavar ® 58 Lenalidomide 58 tanespimycin 58 DAVANAT 58 TYKERB 58 temsirolimus 58 abiraterone 58 Sym# 57 TELCYTA 57 phase IIb 57 Chronic Lymphocytic Leukemia 57 TRITON TIMI 57 Mylotarg 57 RTOG 57 Erlotinib 57 Lapatinib 57 Sorafenib 57 seliciclib 57 relapsed multiple myeloma 57 Azedra 57 PF # [001] 57 glufosfamide 57 Idenix Pharmaceuticals 57 MDV# 57 refractory multiple myeloma 57 sunitinib 57 SUTENT 57 CoFactor 57 Vectibix 57 Gynecologic Oncology Group 57 nilotinib 57 degarelix 57 plus dexamethasone 57 Phase III randomized 56 sorafenib 56 FOLFIRI 56 Virulizin R 56 malignant pleural mesothelioma 56 neoadjuvant chemotherapy 56 SABCS 56 gefitinib 56 ZD# [001] 56 TNFerade 56 BAY #-# 56 double blinded placebo 56 IMC A# 56 ponatinib 56 relapsed refractory multiple myeloma 56 OPAXIO 56 gastrointestinal stromal tumors 56 chemoradiotherapy 56 colorectal cancer CRC 56 neoadjuvant 56 TG# [001] 56 ROTATEQ 56 Immunogen 56 NSCLC